Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...
Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.
Tori Allen says she’s thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more ...
More and more people are taking weight loss injectables like Wegovy and Mounjaro — and pharmacy experts are worried that not ...
A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans.
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
More than 69.2 million FDA-approved weight-loss prescriptions were dispensed in the U.S. from July 2017 through February 2024 ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.
Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.